Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-01-05 @ 11:12 PM
Study NCT ID:
NCT05879458
Status:
TERMINATED
Last Update Posted:
2025-07-18
First Post:
2023-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ritlecitinib in CTCL
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GCO 23-0107
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |